Transcriptional Down-regulation of Epidermal Growth Factor (EGF) Receptors by Nerve Growth Factor (NGF) in PC12 Cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Molecular Neuroscience

• Publication date

  2014-07-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12031-014-0388-2PMID 25078264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemokines and the hippocampus: a new perspective on hippocampal plasticity and vulnerability.

  2013cited by this paper
• Nerve growth factor: basic studies and possible therapeutic applications

  2013cited by this paper
• Near Infrared Optical Visualization of Epidermal Growth Factor Receptors Levels in COLO205 Colorectal Cell Line, Orthotopic Tumor in Mice and Human Biopsies

  2013cited by this paper
• Neurotrophins and their receptors in breast cancer.

  2012cited by this paper
• Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor

  2012cited by this paper
• Role of Neurotrophins in the Development and Function of Neural Circuits That Regulate Energy Homeostasis

  2012cited by this paper
• Global Expression Analysis Identified a Preferentially Nerve Growth Factor-induced Transcriptional Program Regulated by Sustained Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) and AP-1 Protein Activation during PC12 Cell Differentiation*

  2011cited by this paper
• Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling

  2010cited by this paper
• Neurotrophic factor control of adult SVZ neurogenesis

  2010cited by this paper
• Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agents.

  2010cited by this paper
• Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

  2010cited by this paper
• Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75NTR Activity Is Neurotoxic through a Paracrine Mechanism*

  2010cited by this paper
• Quantitative Assessment of Neuronal Differentiation in Three-dimensional Collagen Gels Using Enhanced Green Fluorescence Protein Expressing PC12 Pheochromocytoma Cells

  2009cited by this paper
• In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons.

  2009cited by this paper
• Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer

  2008cited by this paper
• Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis

  2008cited by this paper
• The role of neurotrophins during early development.

  2008cited by this paper
• Temporal and functional dynamics of the transcriptome during nerve growth factor‐induced differentiation

  2008cited by this paper
• Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways.

  2007cited by this paper
• A novel real-time system to monitor cell aggregation and trajectories in rotating wall vessel bioreactors.

  2006cited by this paper
• The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways

  2006cited by this paper
• Beyond proliferation--cell cycle control of neuronal survival and differentiation in the developing mammalian brain.

  2005cited by this paper
• You Can’t Go Home Again: Transcriptionally Driven Alteration of Cell Signaling by NGF

  2005cited by this paper
• Differential distributions of peptides in the epidermal growth factor family and phosphorylation of ErbB 1 receptor in adult rat brain.

  2005cited by this paper
• GCF2: expression and molecular analysis of repression.

  2003cited by this paper
• Nerve growth factor regulates neuroectodermal tumor cell responses to mitogenic growth factors

  2003cited by this paper
• Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections

  2002influential reference
• EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells.

  2002cited by this paper
• A quantitative bioassay for nerve growth factor, using PC12 clones expressing different levels of trkA receptors

  2002cited by this paper
• Nerve growth factor signaling, neuroprotection, and neural repair.

  2001cited by this paper
• Neuronal apoptosis at the G1/S cell cycle checkpoint

  2001cited by this paper
• Effects of basic fibroblast growth factor on central nervous system functions.

  2001cited by this paper
• Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.

  2001cited by this paper
• Functional brain development in humans

  2001cited by this paper
• Genetic regulation of cerebellar development

  2001cited by this paper
• The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells*

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Biology of HER2 and Its Importance in Breast Cancer

  2001cited by this paper
• Cell death in early neural development: beyond the neurotrophic theory.

  2000cited by this paper
• Neurotrophin signal transduction in the nervous system.

  2000cited by this paper
• Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors.

  2000cited by this paper
• Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells.

  2000cited by this paper
• Cloning and Characterization of the Promoter Region of the Rat Epidermal Growth Factor Receptor Gene and Its Transcriptional Regulation by Nerve Growth Factor in PC12 Cells*

  2000cited by this paper
• Mediation of Nerve Growth Factor-driven Cell Cycle Arrest in PC12 Cells by p53

  2000cited by this paper
• Transcriptional Down-regulation of Epidermal Growth Factor Receptors by Nerve Growth Factor Treatment of PC12 Cells*

  1998influential reference
• Molecular Cloning and Characterization of a Transcription Regulator with Homology to GC-binding Factor*

  1998cited by this paper
• A strain‐independent postnatal neurodegeneration in mice lacking the EGF receptor

  1998cited by this paper
• Growth factor synergism and antagonism in early neural crest development.

  1998cited by this paper
• Down-regulation of Epidermal Growth Factor Receptors by Nerve Growth Factor in PC12 Cells Is p140trk-, Ras-, and Src-dependent*

  1997influential reference
• Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain

  1997cited by this paper
• Transcriptional activation of the human epidermal growth factor receptor promoter by human p53

  1996cited by this paper
• Biochemical characterization of human GCF transcription factor in tumor cells.

  1995cited by this paper
• Expression of a Trk high affinity nerve growth factor receptor in the human prostate.

  1995cited by this paper
• WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

  1995cited by this paper
• Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells.

  1994cited by this paper
• Wild-type human p53 activates the human epidermal growth factor receptor promoter.

  1994cited by this paper
• CNTF, FGF, and NGF collaborate to drive the terminal differentiation of MAH cells into postmitotic neurons.

  1994cited by this paper
• Induction of epidermal growth factor receptor gene transcription by transforming growth factor beta 1: association with loss of protein binding to a negative regulatory element.

  1994cited by this paper
• Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor.

  1993cited by this paper
• Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism.

  1993cited by this paper
• Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism.

  1993cited by this paper
• Expression and chromosomal localization of the gene for the human transcriptional repressor GCF.

  1992cited by this paper
• Epidermal growth factor and the nervous system.

  1991cited by this paper
• Acute Regulation of the Epidermal Growth Factor Receptor in Response to Nerve Growth Factor

  1991cited by this paper
• Effects of growth factors on the differentiation of neural crest cells and neural crest cell-derivatives.

  1991cited by this paper
• PDGF A-chain gene is expressed by mammalian neurons during development and in maturity.

  1991cited by this paper
• A review of insulin/insulin-like peptide in the central nervous system.

  1991cited by this paper
• Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene.

  1990cited by this paper
• Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654.

  1990cited by this paper
• Nuclear factor ETF specifically stimulates transcription from promoters without a TATA box.

  1989cited by this paper
• Cell cycle‐specific action of nerve growth factor in PC12 cells: differentiation without proliferation.

  1989cited by this paper
• Regulation of the differentiation of PC12 pheochromocytoma cells.

  1989cited by this paper
• Molecular cloning and characterization of a human DNA binding factor that represses transcription

  1989influential reference
• Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor.

  1988cited by this paper
• The epidermal growth factor receptor as a substrate for a kinase-splitting membranal proteinase.

  1988cited by this paper
• Epidermal growth factor (EGF) receptor gene transcription

  1988cited by this paper
• A transcription factor active on the epidermal growth factor receptor gene.

  1988cited by this paper
• Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nuclease

  1988cited by this paper
• Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture

  1988cited by this paper
• Down‐modulation of EGF receptors in cells transformed by the src oncogene

  1987cited by this paper
• Long-term, heterologous down-regulation of the epidermal growth factor receptor in PC12 cells by nerve growth factor

  1987influential reference
• Norepinephrine decreases EGF binding in primary rat hepatocyte cultures

  1986cited by this paper
• Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model

  1985cited by this paper
• Nerve growth factor-treated, neurite-bearing PC12 cells continue to synthesize DNA

  1985cited by this paper
• Regulation of epidermal growth factor receptor levels by thyroid hormone.

  1984cited by this paper
• Vasopressin inhibition of epidermal growth factor binding to cultured mouse cells.

  1981cited by this paper
• Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells

  1981cited by this paper
• Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors

  1979cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper

• PROTAC-based degradation of catechol-O-methyltransferase for potential treatment of Parkinson’s disease

  2026cites this paper
• The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer

  2024cites this paper
• The Heterogeneity of Response of PC12 Cells from Different Laboratories to Nerve Growth Factor and Pituitary Adenylate Cyclase-Activating Polypeptide Questions the Reproducibility of Studies Carried Out with Tumor Cell Lines

  2021cites this paper
• miR‐22‐3p enhances the intrinsic regenerative abilities of primary sensory neurons via the CBL/p‐EGFR/p‐STAT3/GAP43/p‐GAP43 axis

  2020cites this paper
• Vitamin D and Its Potential Interplay With Pain Signaling Pathways

  2020cites this paper
• RNA Sequencing of Peripheral Blood Revealed that the Neurotropic TRK Receptor Signaling Pathway Shows Apparent Correlation in Recovery Following Spinal Cord Injury at Small Cohort

  2019cites this paper
• Pilose antler peptide protects osteoblasts from inflammatory and oxidative injury through EGF/EGFR signaling.

  2017cites this paper
• Effect of steroidal saponins-loaded nano-bioglass/phosphatidylserine/collagen bone substitute on bone healing

  2017cites this paper
• Signaling Pathways Relevant to Nerve Growth Factor-induced Upregulation of Transient Receptor Potential M8 Expression.

  2017cites this paper
• Delta‐9‐tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation

  2017cites this paper
• Effect of steroidal saponins-loaded composite scaffolds on bone healing

  2016cites this paper